Further investigation of the α-adrenoceptor-mediated actions of chloroethylclonidine in rat aorta

European Journal of Pharmacology

Volumn 336, Issue 1, 1997, Pages 37-42

  O'Rourke, Mary ^a   Gavin, Katherine ^a   Docherty, James R ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

1 Adrenoceptor; 2 Adrenoceptor; Aorta; Chloroethylclonidine; Prazosin; Rat; Spleen; Submandibular gland

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; CHLOROETHYLCLONIDINE; METHOXYIDAZOXAN; NORADRENALIN; PHENOXYBENZAMINE; PRAZOSIN; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

ADRENERGIC ALPHA-ANTAGONISTS; AGE FACTORS; ANIMALS; AORTA; CLONIDINE; MALE; NOREPINEPHRINE; PHENOXYBENZAMINE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2; SPLEEN;

EID: 0030782667     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01257-0     Document Type: Article

References (21)

1. 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen. Br. J. Pharmacol. 109:1993;80-87.
2. Bultmann R., Starke K. Chloroethylclonidine: An irreversible agonist at prejuctional alpha 2 adrenoceptors in rat vas deferens. Br. J. Pharmacol. 108:1993;336-341.
3. 2-adrenoceptors. Br. J. Pharmacol. 101:1990;285-290.
4. Docherty J.R. Cardiovascular responses in ageing: A review. Pharmacol. Rev. 42:1990;103-125.
5. Docherty J., O'Rourke M. The α-adrenoceptor mediated actions of chloroethylclonidine. Gen. Pharmacol. 28:1997;197-201.
6. 1-Adrenoceptor responsiveness in the aging aorta. Eur. J. Pharmacol. 274:1995;117-123.
7. 1-adrenoceptors in rat blood vessels. Eur. J. Pharmacol. 190:1990;97-104.
8. 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens. Br. J. Pharmacol. 111:1994;1003-1008.
9. Leclerc G., Rouot B., Schwaretz J., Velly J. Studies on some para-substituted clonidine derivatives that exhibit an α-adrenoceptor stimulant activity. Br. J. Pharmacol. 71:1980;5-9.
10. 2-adrenoceptor subtypes. Mol. Pharmacol. 44:1993;1165-1170.
11. 1-adrenoceptors involved in noradrenaline induced contractions of rat thoracic aorta and dog carotid artery. Jpn. J. Pharmacol. 57:1991;535-544.
12. Nunes J.P., Guimaraes S. Chloroethylclonidine irreversibly activates postjunctional alpha2-adrenoceptors in the dog saphenous vein. Naunyn-Schmiedebergs Arch. Pharmacol. 348:1993;264-268.
13. Oriowo M.A., Bevan J.A. Chloroethylclonidine unmasks a non-adrenoceptor noradrenaline binding site in the rat aorta. Eur. J. Pharmacol. 178:1990;243-246.
14. 1-adrenoceptors in mammalian aortae: Subclassification based on chloroethylclonidine, WB 4101 and nifedipine. J. Vasc. Res. 29:1992;33-40.
15. O'Rourke M., Kearns S., Docherty J.R. Investigation of the actions of chloroethylclonidine in rat aorta. Br. J. Pharmacol. 115:1995;1399-1406.
16. 1-adrenoceptor. Eur. J. Pharmacol. 199:1991;279-289.
17. Piascik M.T., Sparks M.S., Pruitt T.A. Effect of chloroethylclonidine on arterial blood pressure and heart rate in conscious rat. J. Pharmacol. Exp. Ther. 262:1992;901-906.
18. Ping P., Faber J.E. Characterization of α-adrenoceptor gene expression in arterial and venous smooth muscle. Am. J. Physiol. 265:1993;H1501-H1509.
19. 1D. Biochem. Biophys. Res. Commun. 200:1994;1177-1184.
20. 2D-subtype? Eur. J. Pharmacol. 219:1992;203-210.
21. Tian W.N., Gupta S., Deth R.C. Species differences in chlorethylclonidine antagonism at vascular α-1 adrenergic receptors. J. Pharmacol. Exp. Ther. 253:1990;877-883.